Results 51 to 60 of about 6,592 (211)

Novel Combination of UVA‐1 Phototherapy With Topical Tofacitinib for Treating Eosinophilic Fasciitis With Morphea: Case Report

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Eosinophilic fasciitis (EF) and morphea are rare sclerosing connective tissue disorders, and there remains debate about whether these entities are pathologically distinct or related. This case report describes the successful treatment of an adolescent patient who developed progressive morphea plaques while being treated with systemic ...
Daphne M. Cheung   +5 more
wiley   +1 more source

Generalized morphea following radiotherapy for an intracranial tumor

open access: yesIndian Journal of Dermatology, 2016
Morphea is a localized scleroderma variety which can be circumscribed or generalized and is characterized by sclerotic plaques developing on trunk and limbs. Surgery and radiation have been implicated as etiological factors for the development of morphea.
Shrenik Balegar   +4 more
doaj   +1 more source

Calcinosis Cutis and Delayed‐Onset Myositis in a Case of Suspected Localized Scleroderma: A Diagnostic and Therapeutic Challenge

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT A 16‐year‐old girl presenting with calcinosis cutis and localized scleroderma subsequently developed delayed‐onset idiopathic inflammatory myopathy five years after initial skin involvement. Despite the absence of typical dermatomyositis features and negative myositis‐specific antibodies, whole‐body MRI revealed extensive subclinical muscle ...
Edoardo Marrani   +5 more
wiley   +1 more source

Profiling of Toll-like Receptors and Related Signaling Mediators in the Pathogenesis of Morphea

open access: yesDermatology Practical & Conceptual
Introduction: Morphea, also known as localized scleroderma, is a rare fibrosing inflammatory disease of unknown pathogenesis. Objectives: Although the genetic basis for morphea is important, the evaluation of Toll-like receptors (TLR) in this disease ...
Hilal Ayvaz Celik   +4 more
doaj   +1 more source

Extensive morphea profunda with autoantibodies and benign tumors: A rare case report

open access: yesIndian Dermatology Online Journal, 2012
The term deep morphea describes a variant of morphea (localised scleroderma) in which inflammation and sclerosis are found in the deep dermis, panniculus, fascia or superficial muscle. It is sometimes associated with autoantibodies. We report the case of
Leelavathy Budamakuntla   +1 more
doaj   +1 more source

Case of generalized morphea complicated with systemic sclerosis

open access: yesDermatology Reports, 2021
Dear Editor, Localized scleroderma (LSc; morphea) is a rare fibrosing disease of the skin and underlying tissues, which is different from systemic sclerosis (SSc).
Soichiro Sawamura   +4 more
doaj   +1 more source

Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature [PDF]

open access: yes, 2007
BACKGROUND: Eosinophilic fasciitis is a rare scleroderma-like illness. The clinical spectrum of the disease has evolved since its initial description. METHODS: We identified all patients diagnosed with eosinophilic fasciitis over the past 10 years at our
Bischoff, Lindsay, Derk, Chris T
core   +2 more sources

Autoantibodies in Morphea: An Update

open access: yesFrontiers in Immunology, 2019
Skin autoimmune conditions belong to a larger group of connective tissue diseases and primarily affect the skin, but might also involve underlying tissues, such as fat tissue, muscle, and bone.
Sangita Khatri   +4 more
doaj   +1 more source

Sklerodermie [PDF]

open access: yes, 2018
Zusammenfassung: Die Sklerodermie (Synonyme: systemische Sklerose, systemische Sklerodermie) ist eine Systemerkrankung, die neben der Haut auch innere Organe wie die Lunge, den Gastrointestinaltrakt, die Niere und das Herz befällt.
Distler, O., Gay, S.
core   +1 more source

Elevated Risk of Herpes Zoster in Vitiligo Patients: A Nationwide Population‐Based Cohort Study of Taiwan

open access: yesThe Journal of Dermatology, Volume 53, Issue 4, Page 596-604, April 2026.
ABSTRACT Emerging therapies for vitiligo, such as Janus kinase (JAK) inhibitors, have raised concerns about an increased risk of herpes zoster (HZ), emphasizing the need to clarify the baseline HZ risk in patients with vitiligo. This study aimed to determine whether vitiligo itself is associated with a higher risk of HZ and to identify potential ...
Bing‐Sian Lin   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy